Literature DB >> 16787161

The use of Qtrap technology in drug metabolism.

Richard King1, Carmen Fernandez-Metzler.   

Abstract

Advances in mass spectrometry continue to bring new and exciting capabilities to the study of drug metabolism. This review covers the hybrid linear ion trap - triple quadrupole mass spectrometer, the QTrap. While still a recent addition to the arsenal of mass spectrometry techniques available to the metabolism scientist, reports in the literature highlight the advantages of the system for metabolite identification. The system combines the selective scans of the triple quadrupole with the high speed, high sensitivity of the ion trap allowing metabolites to be found and characterized in a single scan. Additionally, the system has MS(3) and time delayed fragmentation scans that aid in structure elucidation. Since the fragmentation occurs in the collision cell of the triple quadrupole, the traditionally rich fragmentation of the collision cell fragmentation is preserved. In addition to helping to make traditional processes more efficient, work has been done that shows the potential of the instrument to change traditional DMPK approaches. Researchers have reported methods that allow for both qualitative analysis of circulating metabolites and quantification of parent drug within the same analysis. The approaches reported show how the instrument can be used to collect more information from every sample and potentially streamline typical drug metabolism assays.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787161     DOI: 10.2174/138920006777697936

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  8 in total

Review 1.  DNA adducts: Formation, biological effects, and new biospecimens for mass spectrometric measurements in humans.

Authors:  Byeong Hwa Yun; Jingshu Guo; Medjda Bellamri; Robert J Turesky
Journal:  Mass Spectrom Rev       Date:  2018-06-11       Impact factor: 10.946

2.  Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats.

Authors:  Phumon Sookwong; Kiyotaka Nakagawa; Ikuko Fujita; Naoki Shoji; Teruo Miyazawa
Journal:  Lipids       Date:  2011-07-06       Impact factor: 1.880

3.  LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma.

Authors:  Naoki Shoji; Kiyotaka Nakagawa; Akira Asai; Ikuko Fujita; Aya Hashiura; Yasushi Nakajima; Shinichi Oikawa; Teruo Miyazawa
Journal:  J Lipid Res       Date:  2010-04-12       Impact factor: 5.922

4.  A novel strategy for the targeted analysis of protein and peptide metabolites.

Authors:  Nicholas A Williamson; Charles Reilly; Chor-Teck Tan; Sri-Harsha Ramarathinam; Alun Jones; Christie L Hunter; Francis R Rooney; Anthony W Purcell
Journal:  Proteomics       Date:  2010-12-15       Impact factor: 3.984

5.  Identification of the position of mono-O-glucuronide of flavones and flavonols by analyzing shift in online UV spectrum (lambdamax) generated from an online diode array detector.

Authors:  Rashim Singh; Baojian Wu; Lan Tang; Zhongqiu Liu; Ming Hu
Journal:  J Agric Food Chem       Date:  2010-09-08       Impact factor: 5.279

6.  The Application of Mass Spectrometry in Drug Metabolism and Pharmacokinetics.

Authors:  Ji-Yoon Lee; Sang Kyum Kim; Kiho Lee; Soo Jin Oh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Analysis of the in vitro metabolites of diferuloylmethane (curcumin) by liquid chromatography--tandem mass spectrometry on a hybrid quadrupole linear ion trap system: newly identified metabolites.

Authors:  Constantin Tamvakopoulos; Zacharias D Sofianos; Spiros D Garbis; Panayotis Pantazis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jan-Mar       Impact factor: 2.441

8.  Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration.

Authors:  Takahiro Harigae; Kiyotaka Nakagawa; Taiki Miyazawa; Nao Inoue; Fumiko Kimura; Ikuo Ikeda; Teruo Miyazawa
Journal:  Int J Nanomedicine       Date:  2016-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.